Pharmaceutical Technology
  January Issue Preview
 

Pharmaceutical Technology is the only peer-reviewed publication serving the largest requested circulation of 38,600 BPA-audited subscribers (June 2010 BPA Statement). Here is the January editorial lineup to give you a heads up on the coverage in this issue and to assist you in your decision to advertise in Pharmaceutical Technology this month.

Ad close is December 3 and your ad materials will be due on December 16.

 
 
 
Cover Story: The Year Ahead: Industry Leaders Roundtable

Patricia Van Arnum, Senior Editor, Pharmaceutical Technology
Pharmaceutical company executives share their perspectives on the market, strategic, and technical considerations shaping pharmaceutical manufacturing. Topics discussed include decision factors in outsourcing versus captive production, the current and future role of emerging markets, and manufacturing considerations in the shifting product mix between small-molecule and large-molecule drugs and solid-dosage and parenteral drug forms. Also included will be a look at continuous manufacturing and the future of quality by design in pharmaceutical operations.
 

VALUE ADDED MARKETING SUPPORT WITH YOUR JANUARY DISPLAY AD:
• FREE 1/3 Page Trouble Shooting Advertorial (Outline Tools and Solutions)
• FREE 4-Color Print Release

 

EDITORIAL PREVIEW
January 2011

Editorial Content Subject To Change


Interview with the

Special Report: CAPA and Manufacturing Deviations
Angie Drakulich, Managing Editor, Pharmaceutical Technology

Pharma Ingredients Report: APIs and Excipients: Custom Synthesis
Patricia Van Arnum, Senior Editor, Pharmaceutical Technology


PEER REVIEWED RESEARCH
REGULATION AND ANALYSIS An Initial Report of CDER’s Recall Root Cause Research Project

EXTRUSION; DESIGN OF EXPERIMENTS Comparison of Three Extrusion Systems on the Properties of Pellets Prepared by Extrusion-Spheronization




COLUMNS
  • In the Field: Report from Europe and Global Healthcare on the Ground
  • Agent-In-Place
  • In the Spotlight: Focus on Automation/Process Control/IT focus
  • Washington Report
  • NEW: Biologics Column
  • Inside ICH-FDA
  • Pharma Capsules: Industry Leader Q&A
  • Outsourcing Outlook
  • Viewpoint

 

 

 
BONUS DISTRIBUTION
  • Informex


We look forward to hearing from you!
Contact Your Representative:
   
             
Suzanne Fillweber
Tel: 732-346-3024
Email
  Paul Milazzo
Tel: 732-346-3025
Email
  Irene Onesto
Tel: 847-496-4619
Email
  Mike Tracey
Tel: 732-346-3027
Email